n.a. (BRLI)

34.61
0.34 0.97
NASDAQ
Prev Close 34.95
Open 34.74
Day Low/High 34.03 / 34.96
52 Wk Low/High /
Volume 423.74K
Exchange NASDAQ
Div & Yield N.A. (N.A)
UPDATE -- BioReference Laboratories, Inc. Reports Record Quarterly Results Based On Sustained Growth

UPDATE -- BioReference Laboratories, Inc. Reports Record Quarterly Results Based On Sustained Growth

Quarterly Revenues Highest in Corporate History

BioReference Laboratories, Inc. Reports Record Quarterly Results Based On Sustained Growth

BioReference Laboratories, Inc. Reports Record Quarterly Results Based On Sustained Growth

Quarterly Revenues and Earnings Highest in Corporate History

July Options Now Available For Bio-Reference Laboratories (BRLI)

July Options Now Available For Bio-Reference Laboratories (BRLI)

Investors in Bio-Reference Laboratories, Inc. saw new options begin trading today, for the July expiration.

BRLI Crosses Above Key Moving Average Level

BRLI Crosses Above Key Moving Average Level

In trading on Friday, shares of Bio-Reference Laboratories, Inc. crossed above their 200 day moving average of $27.54, changing hands as high as $27.58 per share.

A Lower Stock Price Never Turns A Bad Company Into A Good One

A Lower Stock Price Never Turns A Bad Company Into A Good One

When it comes to portfolio moves, we're cold-blooded in our analysis.

The post A lower stock price never turns a bad company into a good one appeared first on Smarter Investing.

Bio-Reference Laboratories, Inc. Announces Strong Growth Resulting In Record First Quarter Revenue And Earnings

Bio-Reference Laboratories, Inc. Announces Strong Growth Resulting In Record First Quarter Revenue And Earnings

Q1FY13 Results Reported in Accordance With Update 954 Reclassifications

5 Hated Stocks Poised to Pop on Earnings

5 Hated Stocks Poised to Pop on Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Bio-Reference Laboratories, Inc. Announces Record Revenues And Earnings For Fourth Quarter And For Full Fiscal Year Despite Effects Of Hurricane Sandy

Bio-Reference Laboratories, Inc. Announces Record Revenues And Earnings For Fourth Quarter And For Full Fiscal Year Despite Effects Of Hurricane Sandy

(except for per share data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc.

BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2012

BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2012

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the fourth quarter and year end for fiscal year 2012 before the open of market trading on Thursday, December 6, ...

5 Short-Squeeze Plays for Profit

5 Short-Squeeze Plays for Profit

You only need to find a few of these stocks in a year to help enhance your portfolio returns -- the gains become so outsized in such a short time frame that your profits add up quickly.

'Mad Money' Lightning Round: Hold Yahoo! and Buy More

'Mad Money' Lightning Round: Hold Yahoo! and Buy More

Cramer also thinks Dunkin' Donuts and Discover are buys but wants you to avoid Netflix and Hudson City Bancorp.

Cramer's 'Mad Money' Recap: China's Importance

Cramer's 'Mad Money' Recap: China's Importance

China posted some of its strongest economic numbers for the year, Cramer said, and that helped U.S. companies dependant on the Middle Kingdom's business.

A Meat-Grinder Price Zone

The S&P 500 is unlikely to give way without fundamental support, but market players may wait for the election to react.

4 Health Care Stocks Rising on Major Volume

4 Health Care Stocks Rising on Major Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Bio-Reference Laboratories' CEO Discusses Q3 Results - Earnings Call Transcript

Bio-Reference Laboratories' CEO Discusses Q3 Results - Earnings Call Transcript

Bio-Reference Laboratories' CEO Discusses Q3 Results - Earnings Call Transcript

Bio-Reference Laboratories, Inc. Reports Best Quarterly Revenues And Earnings In Corporate History With 25% Increase In Earnings Per Share

Bio-Reference Laboratories, Inc. Reports Best Quarterly Revenues And Earnings In Corporate History With 25% Increase In Earnings Per Share

(Except for Per Share Data or where otherwise noted, numbers are in thousands) Bio-Reference Laboratories, Inc.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

BioReference Laboratories, Inc. Announces Earnings Date For Third Quarter Fiscal Year 2012

BioReference Laboratories, Inc. Announces Earnings Date For Third Quarter Fiscal Year 2012

BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the third quarter of Fiscal 2012 before the open of market trading on Thursday, August 30, 2012.

7 Stocks Rising on Big Volume

7 Stocks Rising on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Bio-Reference Stock Hits New 52-Week High (BRLI)

Bio-Reference Stock Hits New 52-Week High (BRLI)

Bio-Reference Labs (Nasdaq:BRLI) hit a new 52-week high Tuesday as it is currently trading at $26.04, above its previous 52-week high of $25.95 with 114,186 shares traded as of 3:09 p.m. ET. Average volume has been 230,300 shares over the past 30 days.

GenPath Diagnostics Of BioReference Laboratories, Inc. Awarded 2012 Clinical Diagnostics Company Of The Year Award By Frost & Sullivan

GenPath Diagnostics Of BioReference Laboratories, Inc. Awarded 2012 Clinical Diagnostics Company Of The Year Award By Frost & Sullivan

Based on its recent analysis of the clinical diagnostics market, Frost & Sullivan recognized GenPath Diagnostics, a business unit of BioReference Laboratories, Inc.

A Trio of Healthy Choices

The health care industry tends to perform well even in a shaky economy, making BRLI, MGLN and AMSG worth considering.